Functional mesenchymal stem cells remain present in bone marrow microenvironment of patients with leukemia post-allogeneic hematopoietic stem cell transplant

References

• Foran JM, Pavletic SZ, Logan BR, et al. Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myeloid leukemia: a study from the CIBMTR. Biol Blood Marrow Transplant 2013;19:1102–1108.
   PubMed Web of Science ®Google Scholar
• Devetten MP, Hari PN, Carreras J, et al. Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma. Biol Blood Marrow Transplant 2009;15:109–117.
   PubMed Web of Science ®Google Scholar
• Kumar P, Defor TE, Brunstein C, et al. Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival. Biol Blood Marrow Transplant 2008;14:1394–1400.
   PubMed Web of Science ®Google Scholar
• Wang HX, Wang ZD, Xue M, et al. Co-transfusion of haploidentical hematopoietic and mesenchymal stem cells to treat a patient with severe aplastic anemia. Cytotherapy 2010;12:563–565.
   PubMed Web of Science ®Google Scholar
• Wang HX, Yan HM, Duan LN, et al. Haploidentical hematopoietic stem cell transplantation in children hematologic malignancies with G-CSF mobilized marrow grafts without T cell depletion: a single center report of 45 cases. Pediatr Hematol Oncol 2009;26:119–128.
   PubMed Web of Science ®Google Scholar
• Isgrò A, Marziali M, Sodani P, et al. Immunohematologic reconstitution in pediatric patients after T cell-depleted HLA-haploidentical stem cell transplantation for thalassemia. Biol Blood Marrow Transplant 2010;16:1557–1566.
   PubMed Web of Science ®Google Scholar
• Méndez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010;466:829–834.
   PubMed Web of Science ®Google Scholar
• Smith JN, Calvi LM. Concise review: current concepts in bone marrow microenvironmental regulation of hematopoietic stem and progenitor cells. Stem Cells 2013;31:1044–1050.
   PubMed Web of Science ®Google Scholar
• Lawal RA, Calvi LM. The niche as a target for hematopoietic manipulation and regeneration. Tissue Eng Part B Rev 2011;17: 415–422.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143–147.
   PubMed Web of Science ®Google Scholar
• Mercier FE, Ragu C, Scadden DT. The bone marrow at the crossroads of blood and immunity. Nat Rev Immunol 2011;12:49–60.
   PubMed Web of Science ®Google Scholar
• El Haddad N, Heathcote D, Moore R, et al. Mesenchymal stem cells express serine protease inhibitor to evade the host immune response. Blood 2011;117:1176–1183.
   PubMed Web of Science ®Google Scholar
• Chiesa S, Morbelli S, Morando S, et al. Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. Proc Natl Acad Sci USA 2011;108:17384–17389.
   PubMed Web of Science ®Google Scholar
• Lukacs-Kornek V, Malhotra D, Fletcher AL, et al. Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes. Nat Immunol 2011;12: 1096–1104.
   Google Scholar
• Bartsch K, Al-Ali H, Reinhardt A, et al. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used. Transplantation 2009;87:217–221.
   Google Scholar
• Murphy KM. Chimerism analysis following hematopoietic stem cell transplantation. Methods Mol Biol 2013;999:137–149.
   PubMedGoogle Scholar
• Ji SQ, Chen HR, Wang HX, et al. G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia. Bone Marrow Transplant 2002;30:861–866.
   PubMed Web of Science ®Google Scholar
• Zhu H, Guo ZK, Jiang XX, et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc 2010;5:550–560.
   PubMed Web of Science ®Google Scholar
• Jin JD, Wang HX, Xiao FJ, et al. A novel rich source of human mesenchymal stem cells from the debris of bone marrow samples. Biochem Biophys Res Commun 2008;376:191–195.
   PubMed Web of Science ®Google Scholar
• Campagnoli C, Roberts IA, Kumar S, et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001;98:2396–402.
   PubMed Web of Science ®Google Scholar
• Zhu H, Jiang XX, Guo ZK, et al. Tumor necrosis factor-α alters the modulatory effects of mesenchymal stem cells on osteoclast formation and function. Stem Cells Dev 2009;18:1473–1484.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315–317.
   Google Scholar
• Hsu YC, Fuchs E. A family business: stem cell progeny join the niche to regulate homeostasis. Nat Rev Mol Cell Biol 2012;13: 103–114.
   PubMed Web of Science ®Google Scholar
• Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003;425:841–846.
   PubMed Web of Science ®Google Scholar
• Naveiras O, Nardi V, Wenzel PL, et al. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 2009;460:259–263.
   PubMed Web of Science ®Google Scholar
• Stute N, Fehse B, Schröder J, et al. Human mesenchymal stem cells are not of donor origin in patients with severe aplastic anemia who underwent sex-mismatched allogeneic bone marrow transplant. J Hematother Stem Cell Res 2002;11:977–984.
   PubMedGoogle Scholar
• Lee JJ, Nam CE, Kook H, et al. Constitution and telomere dynamics of bone marrow stromal cells in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 2003;32:947–952.
   PubMed Web of Science ®Google Scholar
• Rieger K, Marinets O, Fietz T, et al. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation. Exp Hematol 2005;33:605–611.
   PubMed Web of Science ®Google Scholar
• Dickhut A, Schwerdtfeger R, Kuklick L, et al. Mesenchymal stem cells obtained after bone marrow transplantation or peripheral blood stem cell transplantation originate from host tissue. Ann Hematol 2005;84:722–727.
   Web of Science ®Google Scholar
• García-Castro J, Balas A, Ramírez M, et al. Mesenchymal stem cells are of recipient origin in pediatric transplantations using umbilical cord blood, peripheral blood, or bone marrow. J Pediatr Hematol Oncol 2007;29:388–392.
   PubMed Web of Science ®Google Scholar